A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple Sclerosis

Profound Research, LLC, Carlsbad, California, United States

Neurology Associates, PA, Maitland, Florida, United States

University of South Florida, Tampa, Florida, United States

Shepherd Center Inc., Atlanta, Georgia, United States

John Hopkins University School of Medicine, Baltimore, Maryland, United States

Hope Neurology, Knoxville, Tennessee, United States

Instituto de Neurologia de Curitiba, Curitiba, Paraná, Brazil

Centro de Pesquisas Clinicas, São Paulo, São Paulo, Brazil

Centro de Investigacion Medico Biologico y Terapia Avanzada, S.C., Guadalajara, Jalisco, Mexico

Inovacion y Desarrollo en ciencias de la salud, Mexico City, Mexico CITY (federal District), Mexico

Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

Morriston Hospital, Swansea, United Kingdom